HK1029942A1 - Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma. - Google Patents

Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma.

Info

Publication number
HK1029942A1
HK1029942A1 HK01100916A HK01100916A HK1029942A1 HK 1029942 A1 HK1029942 A1 HK 1029942A1 HK 01100916 A HK01100916 A HK 01100916A HK 01100916 A HK01100916 A HK 01100916A HK 1029942 A1 HK1029942 A1 HK 1029942A1
Authority
HK
Hong Kong
Prior art keywords
glaucoma
effects
treatment
prostaglandin derivatives
derivatives devoid
Prior art date
Application number
HK01100916A
Inventor
Johan Stjernschantz
Bahram Resul
Staffan Lake
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1029942(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of HK1029942A1 publication Critical patent/HK1029942A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK01100916A 1997-07-11 2001-02-09 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma. HK1029942A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702706A SE9702706D0 (en) 1997-07-11 1997-07-11 Prostaglandin derivatives devoid of side effects for the treatment of glaucoma
PCT/SE1998/001368 WO1999002165A1 (en) 1997-07-11 1998-07-10 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
HK1029942A1 true HK1029942A1 (en) 2001-04-20

Family

ID=20407743

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100916A HK1029942A1 (en) 1997-07-11 2001-02-09 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma.

Country Status (19)

Country Link
EP (1) EP1014991A1 (en)
JP (1) JP2002509543A (en)
KR (1) KR20010021682A (en)
CN (1) CN1169528C (en)
AU (1) AU739828B2 (en)
BR (1) BR9815501A (en)
CA (1) CA2294779A1 (en)
HK (1) HK1029942A1 (en)
HU (1) HUP0003106A3 (en)
IL (1) IL133871A (en)
IS (1) IS5333A (en)
NO (1) NO20000062D0 (en)
NZ (1) NZ501834A (en)
PL (1) PL337940A1 (en)
RU (1) RU2207858C2 (en)
SE (1) SE9702706D0 (en)
SK (1) SK183499A3 (en)
TR (1) TR200000008T2 (en)
WO (1) WO1999002165A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803761D0 (en) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
US7456274B2 (en) * 2002-09-16 2008-11-25 Texas Tech University System Inhibition of metallo-β-lactamase
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL212658B1 (en) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Method for obtaining the derivatives of 13,14-dihydro-PGF₂α
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
EP2305304A4 (en) 2008-04-28 2011-08-10 Nat University Corp Hamamatsu University School Of Medicine Immunopotentiating agent comprising ep1 agonist
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
CA2929545C (en) 2009-05-01 2019-04-09 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
EP2488508A4 (en) * 2009-10-16 2013-04-24 Cayman Chemical Co Inc Process for the preparation of f-series prostaglandins
PE20142186A1 (en) 2012-03-28 2014-12-29 Merck Patent Gmbh BICYCLE DERIVATIVES OF PIRAZINONE
JP2012246301A (en) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Method for preparing prostaglandins f
EP4335507A3 (en) 2013-03-15 2024-06-05 Aerie Pharmaceuticals, Inc. Combination therapy
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (en) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Ophthalmic compositions.
MX2019011784A (en) 2017-03-31 2019-11-18 Aerie Pharmaceuticals Inc Aryl cyclopropyl-amino-isoquinolinyl amide compounds.
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085272A (en) * 1977-03-30 1978-04-18 American Cyanamid Company 11-(2-Hydroxyethylthio)prostenoic acid E2 series derivatives
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
EP0664707B1 (en) * 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma

Also Published As

Publication number Publication date
HUP0003106A2 (en) 2001-01-29
AU8368398A (en) 1999-02-08
HUP0003106A3 (en) 2002-12-28
RU2207858C2 (en) 2003-07-10
IL133871A0 (en) 2001-04-30
IS5333A (en) 2000-01-07
SE9702706D0 (en) 1997-07-11
NO20000062L (en) 2000-01-06
PL337940A1 (en) 2000-09-11
TR200000008T2 (en) 2000-05-22
BR9815501A (en) 2001-07-17
KR20010021682A (en) 2001-03-15
EP1014991A1 (en) 2000-07-05
WO1999002165A1 (en) 1999-01-21
CN1262623A (en) 2000-08-09
AU739828B2 (en) 2001-10-18
SK183499A3 (en) 2000-07-11
NZ501834A (en) 2002-05-31
NO20000062D0 (en) 2000-01-06
CA2294779A1 (en) 1999-01-21
JP2002509543A (en) 2002-03-26
IL133871A (en) 2004-09-27
CN1169528C (en) 2004-10-06

Similar Documents

Publication Publication Date Title
HK1029942A1 (en) Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma.
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
PL338563A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
EP1007028A4 (en) 8-iso-prostaglandins for glaucoma therapy
AU5436198A (en) 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
ZA9811629B (en) The use of MMP inhibitors for the treatment of ocular angiogenesis.
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
AU5258698A (en) 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
AU7671198A (en) Methods for the inhibition of neuronal activity by local delivery of adenosi ne
ZA9810033B (en) Process for the preparation of Thiazolidinedione Derivatives.
IL117574A0 (en) Processes for the preparation of cyclobutanone derivatives
DZ2607A1 (en) Process for the synthesis of pharmaceutically active quinoline derivatives.
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
AU4976599A (en) Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
AU2155995A (en) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
ZA968550B (en) Novel processes for the preparation of anti-malarial compounds.
ZA982255B (en) Process for the preparation of arylmalonates.
AU4705997A (en) Individually adaptable sole for reflex zone massage
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080710